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Protein Aggregation Is Not Enough
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M
any damaged and mutant 
polypeptides, as well as 
some normal proteins, 
have a tendency to aggregate in cells. 
Some protein aggregates are capable 
of “dividing” and propagating in 
cells, leading to formation of similar 
aggregates in daughter cells or even in 
neighboring cells due to “infection.” 
These self-propagating protein 
aggregates are called prions and 
constitute the basis of prion diseases. 
The infectious agent in these diseases 
is an abnormal conformation of the 
PrP protein (PrPSc), which makes 
it protease-resistant and initiates its 
aggregation (Prusiner 1998). The 
abnormal aggregated species can 
recruit normal soluble PrP molecules 
into aggregates, thus inactivating them. 
The aggregates of PrPSc can proliferate 
within cells and be transmitted to other 
cells and tissues, leading to the spread 
of neurotoxicity. 
Prion Domains
While so far only one prion protein 
is known in mammals, several prion-
like proteins capable of forming 
self-propagating aggregates have 
been found in various yeast species. 
The common structural feature of 
yeast prion proteins is the so-called 
prion domain, characterized by the 
high content of glutamines (Q) and 
asparagines (N) (DePace et al. 1998; 
Michelitsch and Weissman 2000), 
also known as  the Q/N-rich domain. 
The prion domains are the major 
structural determinants that are 
solely responsible for the polypeptide 
aggregation and propagation of 
the aggregates. Interestingly, the 
mammalian PrPSc is fundamentally 
different from yeast prions, since it 
lacks a Q/N-rich domain, indicating 
that distinct structural features are 
responsible for its ability to form 
self-propagating aggregates. The 
Q/N-rich domains in yeast prions 
are transferable in that, when fused 
to a heterologous polypeptide, 
they confer prion properties to this 
polypeptide. With a low probability, 
soluble proteins with prion domains 
can change conformation to form 
self-propagating aggregates, which 
can be transmitted to daughter cells 
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(Lindquist 1997) (Figure 1). As with 
PrPSc, yeast prions efﬁ  ciently recruit 
soluble molecules of the same species, 
thus inactivating them (Lindquist 
1997; Chernoff 2001; Wickner et al. 
2001). Also with low probability, the 
aggregation-prone conformation of 
yeast prion proteins can reverse to 
a soluble functional conformation. 
Certain yeast prion proteins, when 
in soluble conformation, function 
in important pathways; e.g., Sup35 
(forming [PSI+] prion) controls 
termination of translation, and Ure2 
(forming [URE3+] prion) controls 
some membrane transporter systems. 
Aggregation of these proteins leads 
to phenotypes (e.g., suppression of 
nonsense mutations or transport 
defects) inherited in a non-Mendelian 
fashion owing to the nonchromosomal 
basis of the inheritance.
Inheriting Variations
A remarkable feature of yeast prion 
proteins is their ability to produce 
distinct inherited “variants” of the 
prion. For example, [PSI+] prion could 
exist in several distinct forms that 
suppress termination of translation 
to different degrees. These “variants” 
of yeast prions are analogous to 
different prion “strains” of PrPSc, 
which cause versions of the disease 
with different incubation periods and 
different patterns of brain pathology. 
The molecular nature of distinct 
PrPSc strains is determined by speciﬁ  c 
stable conformations of PrP. Similarly, 
“variants” of yeast prions are explained 
by different stable conformation states 
of the corresponding prion proteins 
(Chien et al. 2003). Strict conformation 
requirements for aggregate formation 
can also explain interspecies 
transmission barriers, where prion 
domains of Sup35 derived from other 
yeast species cannot cause formation 
of [PSI+] prion in Saccharomyces 
cerevisiae, in spite of a high degree 
of homology. This observation is very 
intriguing, especially in light of a recent 
ﬁ  nding that prion conformation of 
some proteins is required for formation 
of prions by the other proteins. For 
example, for de novo formation of 
[PSI+] prion, a distinct prion [RNQ+] 
should be present in a cell (Derkatch 
et al. 2001; Osherovich and Weissman 
2001), probably in order to cross-seed 
Sup35 aggregates. This is in spite of 
relatively limited homology between 
the prion domains of these proteins. 
The apparent contradiction between 
the interspecies transmission barriers 
of very homologous prion proteins and 
possible cross-seeding of aggregates 
by prion proteins with more limited 
homology represents an interesting 
biological problem. On the other 
hand, this apparent contradiction may 
indicate that prion formation is a more 
complicated process than we currently 
think and that it may involve many 
cellular factors.
What Do Prions Do?
Although yeast prions have been 
studied for almost ten years, very 
little is known about their biological 
signiﬁ  cance. We do not know the 
functions of the majority of proteins 
that can exist as prions. Even if a 
function of prion proteins, such as with 
Sup35 or Ure2, is known, we do not 
understand the biological signiﬁ  cance 
of their “prionization,” i.e., that 
they aggregate and propagate in the 
aggregated form. A very intriguing and 
unexpected ﬁ  nding was that formation 
of [PSI+] prion causes a wide variety 
of phenotypic alterations, which 
depend on the strain background 
(True and Lindquist 2000). In fact, 
comparison of yeast strains of different 
origin, each with and without [PSI+] 
prion, showed that certain strains 
with [PSI+] prion have different 
sensitivity to stresses and antibiotics 
than their non-prion derivatives, 
despite their genetic identity. In 
some strains, cells with [PSI+] prion 
demonstrated better survival than 
their non-prion counterparts in the 
presence of inhibitors of translation 
or microtubules, heavy metals, low 
pH, and other deleterious conditions, 
which of course gives a strong 
advantage to the [PSI+] cells. It is likely 
that some genomic mutations could 
be suppressed and therefore become 
silent when termination of translation 
by Sup35 is partially inactivated in 
[PSI+] prion cells (Lindquist 2000; True 
and Lindquist 2000). [PSI+] could also 
reveal previously silent mutations or 
their combinations. It was hypothesized 
that switches between prion and 
non-prion forms of Sup35 enhance 
survival in ﬂ  uctuating environments 
and provide a novel instrument for 
evolution of new traits. 
Q/N Does Not Necessarily 
a Prion Make
Searching genomes of various 
species demonstrated that a relatively 
large fraction of proteins (between 
0.1% and 2%) contain Q/N-rich 
domains (Michelitsch and Weissman 
2000) or polyQ or polyN sequences. 
These domains are often found in 
transcription factors, protein kinases, 
and components of vesicular transport. 
The Q/N-rich domains usually are 
not evolutionary conserved and their 
functional role is largely unknown. 
Some of the Q/N-rich or polyQ 
domains facilitate aggregation of 
polypeptides, especially if expanded 
owing to mutations. Such expansion 
of the polyQ domains in certain 
neuronal proteins could cause 
neurodegenerative disorders, e.g., 
Huntington’s disease or several forms 
of ataxia. Importantly, aggregates 
formed by polypeptides with the 
Q/N-rich or polyQ domains are 
not necessarily self-propagating 
aggregates, i.e., prions. In fact, there 
are additional structural properties 
of the polypeptides that provide the 
self-propagation (see below). Even if 
a protein with a polyQ domain does 
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not form a prion, its aggregation 
may depend on certain prions. 
For example, recent experiments 
demonstrated that [RNQ+] prion 
dramatically stimulated aggregation 
of fragments of recombinant human 
huntingtin or ataxin-3 with an  
expanded polyQ domain cloned in 
yeast (Osherovich and Weissman 2001; 
Meriin et al. 2002). [RNQ+] facilitated 
the nucleation phase of the huntingtin 
fragment aggregation, suggesting that 
this prion can be directly involved 
in seeding of the aggregates. The 
major question now is whether there 
are analogous prion-like proteins in 
mammalian cells that are involved in 
aggregation of huntingtin or ataxin-3 
and subsequent neurodegenerative 
disease. 
The ﬁ  rst indication that mammalian 
proteins with Q/N-rich domains can 
form self-propagating prions came 
from recent work with a regulator of 
translation cytoplasmic polyadenylation 
element-binding protein (CPEB) from 
Aplysia neurons (Si et al. 2003). The 
neuronal form of this protein has a 
Q/N-rich domain similar to the prion 
domains of yeast prions. The Q/N-rich 
domain from CPEB (CPEBQ), when 
fused to green ﬂ  uorescent protein 
(GFP), conferred upon it prion-like 
properties. The CPEBQ–GFP fusion 
polypeptide existed in yeast cells in one 
of the three distinct states, i.e., soluble, 
many small aggregates, or few large 
aggregates. Mother cells almost always 
gave rise to daughter cells in which 
the CPEBQ–GFP polypeptide was in 
the same state, indicating the ability 
of these aggregates to be inherited, 
i.e., to self-propagate. Furthermore, 
full-length Aplysia CPEB protein, when 
cloned in yeast, can also exist in two 
distinct states, soluble and aggregated, 
which is an inherited feature. Very 
unexpectedly, unlike other prions, 
the aggregated state of CPEB was 
more functionally active than the 
soluble form (Si et al. 2003). These 
data strongly suggest that metazoan 
proteins with Q/N-rich domains are 
potentially capable of forming prions. 
The challenge now will be to establish 
whether CPEB can exist as a self-
propagating aggregate in Aplysia or 
mammalian neurons.
Mystery of Propagation
What makes protein aggregates 
in yeast propagate? The key cellular 
element that is critical for this process 
is molecular chaperone Hsp104 
(Chernoff et al. 1995). This factor is 
speciﬁ  cally required for maintenance 
of all known prions within generations 
and probably is not involved in 
prion formation (i.e., initial protein 
aggregation). [PSI+] yeast cells have 
about 60 seeds of this prion (although 
this number differed in different 
[PSI+] isolates), and maintenance of 
about this number of seeds after cell 
divisions requires functional Hsp104 
(Eaglestone et al. 2000). In fact, in the 
absence of Hsp104, prion aggregates 
continue to grow without increase 
in number and are rapidly lost in 
generations (Wegrzyn et al. 2001). 
Since this chaperone can directly bind 
to protein aggregates and promote 
there  disassembly (Glover and 
Lindquist 1998), it was suggested that 
the main function of Hsp104 in prion 
inheritance is to disaggregate large 
prion aggregates to smaller elements, 
thus leading to formation of new 
seeds (Kushnirov and Ter-Avanesyan 
1998). Interestingly, although Hsp104 
is conserved among bacteria, fungi, 
and plants, animal cells do not have 
this chaperone or its close homologs. 
Therefore, if yeast-type prions with 
Q/N-rich domains exist in animal cells, 
there should be alternative factors that 
disaggregate large prion aggregates 
into smaller species in order to keep 
the number of seeds relatively constant 
and thus maintain the prions. 
The fact that some proteins with Q/
N-rich domains form self-propagating 
aggregates, while others can aggregate 
but cannot form prions, suggests 
that there should be some structural 
elements either within the Q/N-rich 
sequence or close to it that confer the 
ability to propagate. In an article in 
this issue of PLoS Biology by Osherovich 
et al. (2004), the authors examined 
sequence requirements for prion 
formation and maintenance of two 
prion proteins, Sup35 and New1. They 
noted that both prion proteins contain 
an oligopeptide repeat QGGYQ in close 
proximity to Q/N-rich sequences and 
examined the functional signiﬁ  cance 
of the repeats for aggregation and 
maintenance of the prions. In New1,  
in contrast to a deletion of the N-rich 
domain,  deletion of the repeat did not 
affect aggregation of the protein or 
formation of the prion, but abrogated 
inheritance of the prion. With Sup35, 
the situation was somewhat more 
complicated, since repeats adjacent to 
Q/N-rich domain affected both protein 
aggregation and prion maintenance 
while more distant repeats affected only 
the prion inheritance. The authors 
suggested that the oligopeptide repeats 
facilitate the division of aggregates, 
either by serving as binding sites for 
Hsp104 or by altering the conformation 
of the polypeptides in aggregates to 
promote access for Hsp104 (Figure 2). 
The likely possibility was that 
the oligopeptide repeats could be 
interchangeable between different 
prions, leading to creation of novel 
chimeric prions. In fact, the authors 
constructed an F chimera, a fusion 
protein having the N-rich domain of 
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New1 and the oligopeptide repeat 
of Sup35. This fusion polypeptide 
efﬁ  ciently formed prion [F+]. 
Furthermore, when the oligopeptide 
repeat sequence was added to a polyQ 
sequence, this fusion polypeptide 
also acquired the ability to form self-
propagating aggregates. This work, 
therefore, clariﬁ  es the architecture 
of prions by deﬁ  ning two structural 
motifs in prion proteins that have 
distinct functions in aggregation 
and propagation. Interestingly, 
not all yeast prions have similar 
oligopeptide repeat motifs, indicating 
that distinct structures could confer 
prion properties to polypeptides that 
can aggregate. It would be important 
to identify these structures in order 
to understand the mechanisms of 
aggregate propagation. The work of 
Osherovich et al. (2004) may help to 
identify proteins from mammalian 
cells, plants, and bacteria that can 
potentially form prions. Finding these 
novel prions could be of very high 
signiﬁ  cance since they may provide 
insight into a wide range of currently 
unexplained epigenetic phenomena.  
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